SCHEMBL1023907

SCHEMBL1023907

C=COc1ccc(C(C)(C)c2ccc(OC=C)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.41
TSHR P16473 3/20 0.41
ESR1 P03372 3/20 0.41
ESR2 Q92731 3/20 0.41
CYP3A4 P08684 2/20 0.41
AR P10275 2/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
HTR6 P50406 1/20 0.41
ESRRG P62508 1/20 0.41
SLC6A3 Q01959 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ALDH1A1 P00352 7/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
MAPT P10636 3/20 0.39
TP53 P04637 2/20 0.39
HIF1A Q16665 2/20 0.39
CYP1A2 P05177 1/20 0.39
PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL754940 0.94 HPGD (0.37) HPGDTSHRESR1ESR2CYP3A4
SCHEMBL14289131 0.94 ESR1 (0.38) HPGDTSHRESR1ESR2CYP3A4
SCHEMBL13018433 0.92 SMN1; SMN2 (0.49) ESR1ESR2CYP3A4ALDH1A1MEN1
SCHEMBL15447941 0.92 TSHR (0.41) HPGDTSHRESR1ESR2CYP3A4
SCHEMBL5025771 0.90 ESR2 (0.59) HPGDTSHRESR1ESR2CYP3A4
SCHEMBL755402 0.86 ESR1 (0.35) HPGDESR1ESR2ALDH1A1MAPT
SCHEMBL3786415 0.86 MAPT (0.47) HPGDTSHRHSD17B10ALDH1A1MAPT
Ethylene Glycol SCHEMBL607522 0.84 KDM4E (0.47) ESR1ESR2CYP3A4ALDH1A1MEN1
SCHEMBL15447939 0.80 HIF1A (0.50) HPGDTSHRARALDH1A1MEN1
SCHEMBL4398260 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117813335-A Curable one-part two-stage thiol-ene-epoxy liquid adhesives and methods 3M创新有限公司 2024-04-02 CN claimed
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film TOKYO OHKA KOGYO CO., LTD. (JP) 2026-03-10 US disclosed
US-20250320180-A1 HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT DIC CORPORATION (JP) 2025-10-16 US disclosed
US-12428559-B2 Curable compositions and methods of making and using the same 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-09-30 US disclosed
EP-4613789-A1 EPOXY COMPOUND PRODUCT Daicel Corporation (JP) 2025-09-10 EP disclosed
US-20250277080-A1 PHENOLIC HYDROXY GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE DIC CORPORATION (JP) 2025-09-04 US disclosed
US-20250277081-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED OBJECT, AND LAMINATE DIC CORPORATION (JP) 2025-09-04 US disclosed
US-12379525-B2 Plastic lens DAICEL CORPORATION (JP) 2025-08-05 US disclosed
US-20250223396-A1 GLYCIDYL ETHER GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAMINATE DIC CORPORATION (JP) 2025-07-10 US disclosed
US-20250206868-A1 METHOD FOR PRODUCING TREATED-SILICA DISPERSED MONOMER COMPOSITION GC CORPORATION (JP) 2025-06-26 US disclosed
EP-0871573-B1 TRANSFER PRINTING MEDIUM MARKEM CORP (US) 2002-03-06 EP disclosed
WO-2001076536-A1 TWO-COMPONENT DENTAL MATERIALS HAVING A LOW SETTING TEMPERATURE 3M ESPE AG (DE) 2001-10-18 WO disclosed
US-6037968-A Scanned marking of workpieces MARKEM CORPORATION (US) 2000-03-14 US disclosed
EP-0728073-B1 TRANSFER PRINTING MEDIUM MARKEM CORP (US) 1999-04-21 EP disclosed
EP-0871573-A4 1998-12-09 EP disclosed
EP-0871573-A2 TRANSFER PRINTING MEDIUM MARKEM CORPORATION (US) 1998-10-21 EP disclosed
US-5757313-A Lacer-induced transfer printing medium and method MARKEM CORPORATION (US) 1998-05-26 US disclosed
WO-1997020696-A2 TRANSFER PRINTING MEDIUM MARKEM CORPORATION (US) 1997-06-12 WO disclosed
EP-0728073-A1 TRANSFER PRINTING MEDIUM MARKEM CORPORATION (US) 1996-08-28 EP disclosed
WO-1995013195-A1 TRANSFER PRINTING MEDIUM MARKEM CORPORATION (US) 1995-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250320180-A1 HYDROXYL GROUP-CONTAINING COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND LAYERED PRODUCT RAD51, SEM1, GFER HPGD 599/4885TSHR 4063/4885ESR1 1003/4885
US-12570858-B2 Curable composition, cured product, cured film, display panel, and method for producing cured film C5, CFL1, C9 HPGD 4873/4885TSHR 967/4885ESR1 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.